Is High Mean Gradient After Edge-to-Edge Strategy Important?

Edge-to-edge treatment of the mitral valve is currently a valid alternative to surgery in cases of mitral regurgitation.

¿Es importante el gradiente medio elevado luego de la estrategia borde a borde?

Different studies have taken residual mitral regurgitation as a parameter of success, but little research has been conducted on the residual gradient once the procedure has been completed

What has been published is that a mean gradient ≥5 mmHg measured by hemodynamics or ≥4.4 mmHg through transesophageal Doppler echocardiography would be related with a poor evolution, as it causes mitral stenosis. However, in recent studies, this information has been subject to controversy (both in relation with primary and secondary regurgitation).

Researchers analyzed 710 consecutive patients who received percutaneous treatment of the mitral valve using the edge-to-edge strategy. Of them, 265 had degenerative mitral regurgitation (DMR) and 445 had secondary mitral regurgitation (SMR).

In the DMR arm, at the end of the procedure 167 patients presented gradient <5 mmHg and 98 ≥5 mmHg; among those with SMR, 347 had a gradient <5 mmHg and 98 ≥5 mmHg.

The primary endpoint (PEP) was a composite of all-cause mortality and readmission for heart failure at 5 years. 

Read also: Improved Ventricular Function Post Revascularization: Fewer Events across Subgroups?

Regardless of the cause of the failure, patients with a high mean gradient had a smaller ventricular diameter.

Patients with DMR had higher rates of hypertension and atrial fibrillation; in contrast, the subjects evaluated in the SMR arm were younger, mostly men, with higher risk scores and greater presence of renal failure. This arm showed a lower ejection fraction on Doppler echocardiography.

There were no differences in complications during the procedure between both groups. 

Read also: Should We Worry about Non-Ischemic Lesions?

There were also no differences in the PEP between the DMR arm (6.3% vs. 74.4%; p = 0.06) and the SMR arm (78.6% vs. 74.8%; p = 0.54). After adjusting for variables, elevated gradient was a predictor of PEP in patients with DMR (hazard ratio [HR]: 1.59; 95% confidence interval [CI]: 1.03-2.45; = 0.034), but not for patients with SMR (HR: 0.87; 95% CI: 0.63-1.22; p = 0.43).

At 12 and 24 months, functional class improved in all patients regardless of whether they had an elevated gradient, and there was also an improvement in the 6-minute walk test (except in patients with DMR with elevated gradient).

Conclusion

Elevated postprocedural mean gradient is an independent predictor of clinical events in patients with degenerative mitral regurgitation, but not in those with functional mitral regurgitation.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Long-Term Outcomes of Patients With Elevated Mitral Valve Pressure Gradient After Mitral Valve Edge-to-Edge Repair.

Reference: Benedikt Koell, et al. J Am Coll Cardiol Intv 2022;15:922–934.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....